These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30299570)
1. Tumor targeting with Rezazadeh F; Sadeghzadeh N Chem Biol Drug Des; 2019 Mar; 93(3):205-221. PubMed ID: 30299570 [TBL] [Abstract][Full Text] [Related]
2. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma. Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411 [TBL] [Abstract][Full Text] [Related]
3. Tumor imaging and therapy using radiolabeled somatostatin analogues. de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476 [TBL] [Abstract][Full Text] [Related]
4. Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of Giammei C; Balber T; Benčurová K; Cardinale J; Berroterán-Infante N; Brandt M; Jouini N; Hacker M; Mitterhauser M; Mindt TL Molecules; 2020 Jun; 25(11):. PubMed ID: 32527027 [TBL] [Abstract][Full Text] [Related]
5. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties. Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571 [TBL] [Abstract][Full Text] [Related]
6. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer. Okarvi SM Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245 [TBL] [Abstract][Full Text] [Related]
7. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes. Smith CJ; Volkert WA; Hoffman TJ Nucl Med Biol; 2005 Oct; 32(7):733-40. PubMed ID: 16243649 [TBL] [Abstract][Full Text] [Related]
8. Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the (99m)Tc(CO)3(+) core. Bouziotis P; Gourni E; Patsis G; Psimadas D; Zikos C; Fani M; Xanthopoulos S; Loudos G; Paravatou-Petsotas M; Livaniou E; Varvarigou AD; Pirmettis I; Papadopoulos M Bioorg Med Chem; 2013 Nov; 21(21):6699-707. PubMed ID: 24035515 [TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. Béhé M; Behr TM Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727 [TBL] [Abstract][Full Text] [Related]
10. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531 [TBL] [Abstract][Full Text] [Related]
11. SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL. Li F; Zhang Z; Cheng T; Wei R; Dai Y; Lv M; Luo D; Zhu X; Ma D; Xi L; Dong Q; Ma X Amino Acids; 2016 Jan; 48(1):91-101. PubMed ID: 26255282 [TBL] [Abstract][Full Text] [Related]
12. Radiolabeled peptides in oncology: role in diagnosis and treatment. Weiner RE; Thakur ML BioDrugs; 2005; 19(3):145-63. PubMed ID: 15984900 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006 [TBL] [Abstract][Full Text] [Related]
14. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors. Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172 [TBL] [Abstract][Full Text] [Related]
15. Imaging of Integrin α Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416 [TBL] [Abstract][Full Text] [Related]
16. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression. Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166 [TBL] [Abstract][Full Text] [Related]
17. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors. Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwé DA; Schubiger PA; Schibli R; García Garayoa E Bioconjug Chem; 2008 Dec; 19(12):2432-9. PubMed ID: 19053304 [TBL] [Abstract][Full Text] [Related]
18. Radiopeptide imaging and therapy in Europe. Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells. Jiménez-Mancilla N; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Isaac-Olivé K; Camacho-López M; Torres-García E J Labelled Comp Radiopharm; 2013 Nov; 56(13):663-71. PubMed ID: 25196028 [TBL] [Abstract][Full Text] [Related]
20. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]